Microscopes Market Share, Size, Trends, Growth, Industry Analysis and Forecast to 2020 | Hexa Research

The global Microscopes Market is projected to reach nearly USD 7.4 billion by 2020. Key factors that drive the industry are technological innovations and surging private sector & government sector investments. Nanotechnology being a continuously evolving field has a favorable impact on overall market demand. Intensive R&D in life sciences & semiconductors is expected to fuel industry growth over the forecast period (2012 to 2020). Popularity of super resolution microscopes can be attributed to continuous technological innovations. Such microscopes are highly effective & convenient especially when it comes to examining complex human body parts, such as the neurological system & the brain.

Introduction of high resolution & cost effective microscopes, such as the dSTORM (direct stochastic optical reconstruction optical microscopy) may catapult demand till 2020. The microscopes market in most developing economies is driven by availability of cheap labor and favorable government policies. Interestingly, these factors fuel demand for semi-conductors and induce greater research in life sciences & nanotechnology.

Browse Details of Report @ https://www.hexaresearch.com/research-report/microscopes-industry

The worldwide microscopes market is categorized on the basis of products, applications, and geographies. As per products, the segments are optical, scanning probe, electron and others. Fueled by high adoption rates in life sciences & semiconductors and widespread applications, optical microscopes generated highest revenues in the overall market in 2013. 

These microscopes are further categorized into near field scanning, confocal scanning, fluorescence, phase contrast, stereomicroscope, inverted, and others. Inverted microscopes held the largest market share in 2013. Applications in metallurgy & micromanipulation could fuel demand for inverted microscopes. This segment is expected to grow robustly over the forecast period.

Based on applications, the global industry is divided into semiconductors, life sciences, nanotechnology, material sciences, and others. The market was led by the life sciences segment in 2013. Demand is mainly fueled by innovations in consumer electronics, and use of microscopes in manufacturing & inspection and in research & development. Newer areas of application, such as miniature transistor chips and quantum dots could drive the overall industry in the forthcoming years. Quantum dots is a gradually evolving technology that may cater to several application areas, like quantum computing, electroluminescent displays, diode lasers, biological imaging, photovoltaic cells, and transistors in the years to come.

Regional segments of the global microscopes market are Europe, Asia Pacific, North America, and Rest of the World. Asia Pacific dominated the overall industry in terms of revenue in 2013. In 2011, China witnessed the highest rate of funding in its nanotechnology industry globally. Industrialization coupled with use of nanotechnology in research & development may create lucrative opportunities for further growth of the global market.

Furthermore, demand for microscopes from noncommercial organizations (hospitals and research laboratories) can also play a significant role in triggering market progress. 

Companies operating in the global industry are Carl Zeiss, Olympus Corporation, Leica Microsystems, and Nikon Corporation. Since there are only a few participants, this market is characterized by minimal competition. It is essentially oligopolistic in nature.

Scientists from Uppsala University, Stockholm University, and University of California have created a 3D printed cell phone attachment that can turn a particular device’s camera into a microscope. Such an innovation aims at helping health workers in developing nations and in remote locations to identify genetic mutations that cause illnesses & diseases. With the help of such a device, healthcare professionals do not need to send samples to laboratories.

 Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blog: hexaresearch1.blogspot.com

Ablation Technology Market Size, Trends, Growth, Industry Analysis and Forecast to 2020 | Hexa Research

The global Ablation Technology Market is primarily driven by high incidence of chronic illnesses, such as cancer. Rising cancer cases fuel the need for minimally invasive procedures for diagnostics purposes. Surgical removal of body tissues is carried out by minimally invasive procedures. These procedures employ ablation technologies. Besides being economical, ablation technologies ensure quick recovery and cause lesser damage to body tissues. They also ensure lower risks of infection.

Favorable government initiatives and a rapidly growing geriatric population are factors that positively impact demand. Owing to high success rates in diagnosis of chronic illnesses and minimal risks, developing economies, such as Brazil, India, Russia, and China are gradually adopting ablation technologies. It is anticipated that popularity of minimally invasive procedures and surging per capita expenditure on healthcare may propel the ablation technology market during the forecast period (2012 to 2020).

Browse Details of Report @ https://www.hexaresearch.com/research-report/ablation-technology-industry

The worldwide industry is segmented on the basis of technologies, applications, and regions. Based on technologies, the Ablation Technology Market is divided into radiofrequency, ultrasound, electrical, and radiation. Due to widespread scope in cancer diagnosis, radiation technology led the global market in 2013. Other factors that may positively impact this segment in the forthcoming years are availability of different types of radiation devices and high incidence of cancer. The segment for electrical ablation may expand robustly over the forecast period. This attributes to rising prevalence of cardiovascular disorders, such as atrial fibrillation.

Ablation technologies are predominantly applied in orthopedics, ophthalmology, cardiovascular procedures, and in cancer. Use of ablation technologies in cancer diagnosis generated the highest revenues in 2013. Growing awareness about the popularity of ablation technology in cancer treatment is projected to fuel overall market demand. Cardiovascular applications are expected to increase considerably over the forecast period.

Geographically, the global ablation technology market is fragmented into Europe, Asia Pacific, North America, and Rest of the World. North America held highest shares in the overall industry back in 2013. Awareness about ablation technologies and large number of people suffering from chronic diseases are key regional drivers. Ongoing industry trends suggest that Asia Pacific may expand remarkably in the years to come. The region is essentially propelled by surging healthcare expenditure and application of ablation technologies in diagnostics solutions. Growing preference for ablation over surgeries and substantial government spending on ablation technology could further contribute to regional demand.

Key companies operating the worldwide market are Boston Scientific Corporation, Olympus Corporation, AngioDynamics Inc., Medtronic Inc., and AtriCulture Inc. among others. Most industry participants focus greatly on innovations that aim at enhancing accuracy & efficiency of test results. Researchers have developed a cryoablation system that can attain much cooler temperatures than most conventional cryoablation technologies.

The new system can effectively create transmural ventricular lesions from the epicardium as well as the endocardium. It may prove beneficial for catheter-based & surgical ventricular tachycardia ablations in humans. This cryoablation technology utilizes liquid nitrogen and achieves temperatures as low as minus 160 degrees Celsius. This IceSense cryoablation system helps debulk tumors in lungs, kidneys, liver, and breast. It comprises a freezing element and a rigid probe that has a sharp needle tip. 

 Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit our Blog: hexaresearch1.blogspot.com

Gynecological Devices Market Research Report, 2024: Hexa Research

Growing healthcare awareness and changing lifestyles are key factors that fuel the global Gynecological Devices Market. The industry is poised to surpass USD 21 billion by the end of the forecast period (2016 to 2024). Rising income levels in developing countries, such as Indonesia, Vietnam, and India may significantly contribute to industry demand in the years to come. High incidence of gynecological anomalies, like menorrhagia, uterine fibroids, and cervical cancer could positively influence global demand.

Gynecological devices are an integral part of the medical devices industry. Adoption of specialized gynecological procedures in hospitals and in healthcare centers fuels the need for such devices. Introduction of sophisticated imaging devices, such as 3D endoscopes holds promise for further market progress. High incidence of diseases, such as uterine fibroids and sexually transmitted diseases can propel demand in the years to come.

Browse Details of Report @ https://www.hexaresearch.com/research-report/gynecological-device-market

The global gynecological devices market is segmented as per products and regions. On the basis of products, the industry is trifurcated into surgical devices, hand instruments, and diagnostic imaging systems. Hand instruments are further segmented into biopsy forceps, vaginal speculum, trocars, tenaculum, curettes, and others. Surgical devices comprise gynecological endoscopy devices, endometrial ablation devices, fluid management systems, and female contraceptive/sterilization devices.

Surgical devices hold the highest share in the overall Gynecological Devices Market because of growing demand for female contraceptives & endoscopy devices. Use of endoscopes in gynecology is gradually increasing. Some of their key applications in gynecology are resectoscopes, endoscopic imaging, hysteroscopes, and laparoscopes. Being minimally invasive, procedures, such as hysterectomy, hysterotomy, and laparoscopy may favorably impact demand for endoscopes in the near future.

Awareness about the importance of early detection of gynecological disorders and use of lighting in diagnostics solutions could play a key role in fuelling industry growth in the years to come.

Geographically, the gynecological devices industry is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. North America generates the highest revenues in the overall industry. High concentration of market competitors and widespread adoption of advanced technologies are key regional drivers. Healthcare centers in the region carry out routine check-ups for women to rule out the possibilities of cervical & breast cancers.

Asia Pacific can witness robust growth over the forecast period. Factors that fuel this region are medical tourism and affordable treatment costs. Most manufacturing facilities are increasingly being established in India & China. Reasons that support such a trend are cheap labor costs, availability of skilled healthcare professionals, and advanced manufacturing facilities. This has also lead to low manufacturing costs of medical devices.

Key companies operating in the global gynecological devices market are Medtronic plc; Stryker Corporation; Cooper Surgical Inc.; Boston Scientific Corporation; and Richard Wolf Gmbh among many others. In September 2016, Aqueduct Medical received FDA (Food and Drug Administration) approval for a device that creates cervical dilation within a few minutes. Aqueduct Medical is an Israel based startup dealing in medical devices. The process is carried out without general anesthesia. At present, the company is conducting clinical trials in Europe. The product would soon be available in Israel once it is approved by the Health Ministry. 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog: hexaresearch1.blogspot.com

Ambulatory Services Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

The global ambulatory services market is projected to expand at a moderate CAGR of nearly 6% over the forecast period (2016 to 2024). The industry was valued approximately USD 2200 billion in 2014. High government expenditure on ambulatory care services plays a vital role in driving market demand.

Implementation of government initiatives that support team-based primary care could positively impact the market in the years to come. Popularity of day surgery centers attributes to technological advancements and reduced hospital stays. Ambulatory services lead to cost savings due to lower hospital stay costs. Unlike conventional surgeries that require long hospital stays, non-surgical methods facilitate day surgeries. This attributes to the availability of resourceful recovery procedures.

The worldwide ambulatory services industry is categorized on the basis of types and regions. As per types, the divisions are primary care offices, outpatient departments, emergency departments, surgical specialty, medical specialty, and others. With revenues surpassing USD 400 billion, primary care offices led the overall market in 2014. Being the initial point of care, primary care has been obtaining strong government support. With substantial financial impetus, governments in a number of regions have successfully established community care centers.

Browse Details of Report @ https://www.hexaresearch.com/research-report/ambulatory-care-services-market

Popularity of same-day surgeries and technological advancements drive the surgery specialty segment. It is anticipated to grow rapidly in the forthcoming years. A number of acquisitions have been taking place over the past couple of years in the market for surgery specialty. In 2015, Apollo Hospital acquired the Nova Medical surgical unit for around USD 24 million. Such collaborations could significantly contribute to this market segment from 2016 to 2024. Several providers of ambulatory health care operate closely with other healthcare providers & physicians to expand their worldwide reach. Tenet Healthcare and United Surgical Partners International came together in 2015 and increased the network for ambulatory healthcare units.  Geographically, the global ambulatory services market is categorized into Asia Pacific, North America, Europe, the Middle East & Africa, and Latin America. North America dominated the industry in 2014. Regional drivers are shift of geriatric patients from inpatient to outpatient care and cost savings brought about by same day surgeries. The ambulatory services market in Europe is a gradually expanding one. The region is fueled by popularity of newer types of anesthesia that cause minimal discomfort to patients. This ensures rapid recovery without hospital stays.

Asia Pacific is poised to grow at a CAGR surpassing 7% over the forecast period. Burgeoning healthcare costs because of widespread prevalence of chronic ailments is causing companies & governments take to the “outpatient” trend. China has introduced mobile apps that facilitate outpatient medical appointments & payments for the same. This app in turn brings down long waiting times.

Prominent companies operating in the worldwide ambulatory services market are Medical Facilities Corporation, Nueterra, Aspen Healthcare, Surgery Partners, and Symbion. Some of the commonly used ambulatory software are ambulatory EHR/EMR, ambulatory practice management (PM), ambulatory patient portal, and ambulatory medical billing. Electronic health records (EHRs) are central repositories for patient and patient-care related data, such as progress notes, lab orders, and medication lists. Practice management systems are repositories for administrative data, such as workflow management, appointment scheduling, and patient registration. In most ambulatory facilities, patient portals are primary methods of communication that takes place between healthcare providers and patients.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog: hexaresearch1.blogspot.com

Bioreactors Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 | Hexa Research

The worldwide bioreactors Market is anticipated to generate revenues over USD 550 million by 2024. It will grow at a CAGR above 18% in the forecast period (2016-2024). The industry is driven by the demand for biologics and adoption of single-use bioreactors (SUBs) & hybrid bioreactors. Rising popularity of SUBs in pharmaceutical manufacturing companies is yet another key driver.

SUBs or disposable bioreactors contain disposable bags instead of cultural vessels. They face high demand from the medical sector. These reactors are adopted by pharmaceutical companies to manufacture drugs without any negotiations on their quality. These systems differ in view of flexibility and cultural medium. Commercial bioreactors include CellMarket Regular from Cellexus and HyClone SUB from Thermo Fisher Scientific.

Low functional costs of SUBs and low maintenance required for them can propel market demand from 2016 to 2024. Moreover, convenience associated with marine-microbe culturing coupled with low energy consumption by SUBs could favor these reactors. But low volume capacities of SUBs can hamper the industry. 

Browse Details of Report@ https://www.hexaresearch.com/research-report/bioreactors-market

The worldwide Bioreactors Market is fragmented on the basis of products, cells, molecules, technologies, end-users, and regions. Products include monoclonal antibodies and recombinant proteins. Monoclonal antibodies are projected to reign owing to their efficiency in medical treatments. Yeast, bacteria, and mammalian cells are the various cells. Mammalian cells should be the most rapidly growing segment. This will be attributed to their high bio-molecular effectiveness.

Recombinant proteins, monoclonal antibodies (MAbs), gene therapy, stem cells, and vaccines are classified under molecules. MAbs are used by biologics industry to manufacture vaccines. This may augments the demand for bioreactors in the next eight years. Low investment costs of SUBs to make MAbs on a small scale can add to overall market demand.

Single use bubble column bioreactor, stirred SUBs, and wave-induced motion SUBs constitute the technologies. Wave-induced motion SUBs are likely to notice the highest growth rate till 2024. Surging growth can be attributed to their high flexibility and short lead times.

End-users in the Bioreactors Market comprise R&D departments and biopharmaceutical manufacturers. The former are sub-divided into biopharmaceutical companies, contract research organizations (CROs), and research institutes.

Regions are Asia Pacific, North America, Europe, and RoW (Rest of the World). North America & Europe would garner major shares by 2024. This will be ascribed to their key biopharmaceutical firms.

Europe is predicted to capture large shares due to biologic drug patents reaching expiry. Also, regional assistance for biologic manufacturers to produce drugs with high effectiveness should benefit the region.

Asia Pacific is likely to display significant expansion because of investment opportunities for its major biologic manufacturers. Key firms opening their manufacturing units in Latin America will benefit the region.

Key companies in the global Bioreactors Market are GE Healthcare, Thermo Fisher Scientific Inc., Merck KGaA, and Sartorius Stedim Biotech S.A. They are expected to further their product portfolio and offer system flexibility.

This could make consumer segments well-acquainted with various blends of bioprocessing components. It can also help them with buying decisions. Product endorsements via commercial manufacturing to obtain the finest application solutions may augur well for the market.

Browse Related Category Market Reports @

https://www.hexaresearch.com/research-category/biotechnology-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Visit Our Blog: hexaresearch1.blogspot.com

STD Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

The global STD (sexually transmitted disease) diagnostics market is driven by growing awareness about STDs among the masses and greater governmental initiatives. Technological developments too play a vital role in fuelling market growth. Popularity of POC (point of care) testing propels the demand for improved products, such as diagnostic devices, kits, and reagents. A number of people have multiple sexual partners which in turn raises the possibility of contracting infections. Hence, there’s the growing need for accurate & precise diagnostics solutions.

The worldwide STD diagnostics market is segmented as per types of infections, location of tests, devices, and regions. On the basis of infections, the categories are human papilloma virus (HPV), syphilis, chlamydia, vaginitis, HIV (human immunodeficiency virus), herpes simplex virus, and gonorrhea. Chlamydia, gonorrhea, and syphilis are sexually transmitted infections (STIs) caused by bacteria.

Browse Details of Report @ https://www.hexaresearch.com/research-report/std-diagnostics-market

Genital warts, HPV, HIV, and hepatitis genital herpes are examples of STIs caused by viruses. These microorganisms get transmitted through semen, blood, and vaginal fluids. Chlamydia is by far the most commonly occurring sexually transmitted disease. In terms of revenues, this segment held the highest share in the overall industry. It generated revenues surpassing USD 36 billion in 2016.  However, rising cases of syphilis may contribute to more than 20% of total industry revenues over the forecast period (2016 to 2024).

Based on location of tests, the market is bifurcated into laboratory testing and point of care (PoC) testing.

Laboratory tests are carried out either in public health labs or in private/commercial labs. Unlike, PoC testing solutions, laboratory tests deliver more precise results. PoC tests (such as test kits) are a more convenient option because these deliver immediate results, but they are not always accurate. The introduction of bedside & mobile testing is a step towards enhanced healthcare. The industry for bedside & mobile testing may expand at a CAGR nearly 10% from 2016 to 2024.

According to type of device, the worldwide STD diagnostics market is segmented into thermal cyclers - PCRs, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate reader, phone chips (microfluidics+ICT), and bench top/portable/rapid diagnostics kits. Portable/rapid diagnostics and phone chips are PoC testing devices, while the others are laboratory test devices. The thermal cyclers segment is anticipated to grow rapidly at a CAGR surpassing 8% during the forecast period. The portable PoC testing devices industry is propelled by continuous technological innovations. It may generate revenues exceeding USD 46 billion by 2024.

Geographically, the global STD diagnostics market is divided into Asia Pacific, North America, Latin America, Europe, and the Middle East & Africa. Driven by surging public awareness about STIs and the presence of a well developed system of health insurance, North America dominates the global industry. Another vital factor that positively impacts this region is the growing accessibility to FDA-approved highly advanced testing devices. As per ongoing industry trends, Asia Pacific may register a high CAGR over the forecast period and thus prove to be a lucrative market in the long run. Prominent companies operating in the worldwide STD diagnostics market are Danaher Corporation, Abbott Laboratories, BioMerieux, Roche Holdings AG, and Becton Dickinson & Company.

Recently, QuantuMDx, a U.K. based company dealing in life sciences diagnostics & tools, developed the Q-Poc. This is a highly affordable diagnostic DNA analyzer which is commonly known as the “handheld lab”. It is capable of diagnosing certain types of cancers and a number of infectious diseases (including the sexually transmitted ones). Equipped with a solar battery, the Q-Poc can analyze biological samples, for example, swabs are used to detect sexually transmitted diseases/infections.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/clinical-diagnostics-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/